Every year more than 450,000 women die from breast cancer. Fortunately, physicians have an arsenal of treatment options against this disease and a new one may have just been developed, report Norbert Herzog and David Niesel in this week’s installment of UTMB’s Medical Discovery News. A group of Canadian researchers doing basic studies on breast cancer cells found a way to determine whether a patient’s breast cancer is likely to be aggressive. What they’ve found is that biochemical signaling among cancer cell proteins can be different in each woman. Remarkably, the researchers could associate the type of signaling with the outcome of the disease. Here’s another example of basic research that on the surface appears esoteric but delivers a powerful new approach to diagnosing disease. MDN airs locally at 10 a.m. Saturday on KUHF.